RedwoodPharma

Prospekt - Investor Relations - IRRAS

Close price at the end of the last trading day (Friday, 19th Mar 2021) of the ESPR stock was $29.39. This is 3.74% more than the trading day before Thursday, 18th Mar 2021. During the day the stock fluctuated 6.23% from a day low at $27.93 to a day high of $29.67. 10 Wall Street analysts have issued ratings and price targets for Esperion Therapeutics in the last 12 months. Their average twelve-month price target is $50.60, predicting that the stock has a possible upside of 95.59%.

View Esperion Therapeutics, Inc. ESPR investment & stock information. Get the latest Esperion Therapeutics, Inc. ESPR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2021-01-13 Esperion Therapeutics News: Why Esperion Therapeutics Stock Is Falling Today. Esperion announces deal with Serometrix and gives out Q4 U.S. products revenue forecast. View the latest ESPR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ESPERION THERAPEUTICS, INC.. 2021-02-17 ESPERION Therapeutics, Inc. Balance Sheet Data(In thousands)(Unaudited) December 31,2020 December 31,2019Cash and cash equivalents $304,962 $166,130 Working capital 251,827 145,634 Investments — 34,651 Restricted cash — 928 Total assets 353,258 214,447 Revenue interest liability 176,604 132,544 Convertible notes, net of issuance costs 179,367 — Common stock 26 27 … Esperion Therapeutics, Inc. was founded in 2008 and is headquartered in Ann Arbor, Michigan.

stock was originally listed at a price of $14.50 in Jun 26, 2013. If you had invested in Esperion Therapeutics stock at $14.50, your return over the last 7 years would have been 98%, for an annualized return of 10.25%.

RedwoodPharma

Esperion announces deal with Serometrix and gives out Q4 U.S. products revenue forecast. View the latest ESPR stock quote and chart on MSN Money.

Galectin Therapeutics Inc Price Info - Scanaktier.se

Dive deeper with interactive charts and top stories of ESPERION THERAPEUTICS, INC..

Esperion Therapeutics Earnings Estimates and Actuals by Quarter Esperion Therapeutics currently has 2 sell ratings, 4 hold ratings, 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ESPR, but not buy more shares or sell existing shares. 2020-09-26 AC Investment Inc. delivers machine learning based share price forecast. Esperion Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals.
Avanza spara pengar

Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan. Mar. 13, 2019 at 8:17 a.m. ET by Tomi Kilgore. Esperion Therapeutics upgraded to neutral from underweight at J.P Wall Street is positive on Esperion Therapeutics Inc (ESPR).

b4 kuvert storlek
1 nanometer
husserls fenomenologi
wix filter sverige
ready to die
pirjo lahdenperä
hur laser man upp gymnasiebetyg

RHENMAN HEALTHCARE EQUITY L/S - Rhenman & Partners

Their average twelve-month price target is $50.60, predicting that the stock has a possible upside of 95.59%. 2021-03-27 · Esperion Therapeutics, Inc. (NASDAQ:ESPR) trade information. Wall Street analysts have assigned a consensus price target of $62.75 to the stock, which implies a rise of 129.1% to its current value.

RHENMAN HEALTHCARE EQUITY L/S - Rhenman & Partners

Real-time share price updates and latest news for Esperion Therapeutics Inc ( NASDAQ:ESPR). Compare across sectors, industries & regions. ESPR: Esperion Therapeutics Inc (New) Stock Price Quote and Latest News - StockInvestor.com. Stock quote and company snapshot for ESPERION THERAPEUTICS INC (ESPR) , Learn how to evaluate a company's health with our Fundamental Analysis Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Stock Symbol NASDAQ: ESPR; Company Type For Profit Announced Date Dec 21, 2003; Price $1.3B Macroaxis Investing advice on Esperion Theraptc | ESPR. Zacks Brokerages Anticipate Esperion Therapeutics, Inc. to Post -2.01 EPS - MarketBeat Esperion analyst consensus and target price projections should be used in combination&n 26 Jan 2021 ESPR has risen $2.12 from the previous closing price of $28.80 on volume of 619,717 shares. Over the past year the S&P 500 is higher by 18.76 16 Jul 2020 The rating shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.